<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">05165</article-id><article-id pub-id-type="doi">10.7554/eLife.05165</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Blood-stage immunity to <italic>Plasmodium chabaudi</italic> malaria following chemoprophylaxis and sporozoite immunization</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-28916"><name><surname>Nahrendorf</surname><given-names>Wiebke</given-names></name><aff><institution content-type="dept">Institute of Immunology and Infection Research</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21519"><name><surname>Spence</surname><given-names>Philip J</given-names></name><aff><institution content-type="dept">Institute of Immunology and Infection Research</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21520"><name><surname>Tumwine</surname><given-names>Irene</given-names></name><aff><institution content-type="dept">Division of Parasitology</institution>, <institution>MRC National Institute for Medical Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29636"><name><surname>Lévy</surname><given-names>Prisca</given-names></name><aff><institution content-type="dept">Division of Parasitology</institution>, <institution>MRC National Institute for Medical Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21522"><name><surname>Jarra</surname><given-names>William</given-names></name><aff><institution content-type="dept">Division of Parasitology</institution>, <institution>MRC National Institute for Medical Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15912"><name><surname>Sauerwein</surname><given-names>Robert W</given-names></name><aff><institution content-type="dept">Department of Medical Microbiology</institution>, <institution>Radboud University Medical Center</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-17881"><name><surname>Langhorne</surname><given-names>Jean</given-names></name><aff><institution content-type="dept">Division of Parasitology</institution>, <institution>MRC National Institute for Medical Research</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country><email>jlangho@nimr.mrc.ac.uk</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-21294"><name><surname>Krzych</surname><given-names>Urszula</given-names></name><role>Reviewing editor</role><aff><institution>Walter Reed Army Institute of Research</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>25</day><month>02</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e05165</elocation-id><supplementary-material><ext-link xlink:href="elife-05165-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>14</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>23</day><month>02</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Nahrendorf et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Nahrendorf et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Protection against malaria in humans can be achieved by repeated exposure to infected mosquito bites during prophylactic chloroquine treatment (chemoprophylaxis and sporozoites (CPS)). We established a new mouse model of CPS immunization to investigate the stage and strain-specificity of malaria immunity. Immunization with <italic>Plasmodium chabaudi</italic> by mosquito bite under chloroquine cover does not generate pre-erythrocytic immunity, which is acquired only after immunization with high sporozoite doses. Instead, CPS immunization by bite elicits long-lived protection against blood-stage parasites. Blood-stage immunity is effective against a virulent, genetically distinct strain of <italic>P. chabaudi</italic>. Importantly, if exposure to blood-stage parasitemia is extended, blood-stage parasites induce cross-stage immunity targeting pre-erythrocytic stages. We therefore show that CPS immunization can induce robust, long-lived heterologous blood-stage immunity, in addition to protection against pre-erythrocytic parasites following high dose sporozoite immunization. Cross-stage immunity elicited by blood-stage parasites may further enhance efficacy of this immunization regimen.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All experiments were performed in accordance with UK Home Office regulations (PPL 80/2358) and approved by the ethical review panel at the MRC National Institute for Medical Research.</p></fn></fn-group></back></article>